Russia has been pushing to incorporate nuclear technology in medicine. This process, known as nuclear medicine, involves the use of radioactive substances producing dangerous radiations to gamma rays, beta particles, and alpha particles. Although it may be risky and unsafe, Russia’s increasing participation in the “international market for the production of medical isotopes” has brought tremendous success to the country in the means for fighting cancer.
While only five countries—Australia, South Africa, Canada, France, and the Netherlands—had been producing radioactive isotopes in the world, Russia has proven to turn the tides for nuclear medicine. Due to hard work, extensive research, and innovation, Russia has taken the lead in the world’s global market for radioisotopes, producing four radioisotopes that destroy cancer cells. These four radioisotopes include: Molybdenum-99, Strontium-89, Gadolinium-152, and Lutetium-177, which are in high demands in the internal and external market and have proven to revolutionize nuclear medicine.
Critics believe that nuclear medicine is the most successful industry when it comes down to treating diseases and conditions that many have believed to be incurable. Because of the need for diversifying products and the safety of isotope production, Russia’s position in this market plays a significant role. In order to save even more lives, Russia had worked to extend nuclear cooperation with other countries, promoting international cooperation and medical advancements all over the world.